Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Christopher Porter

Concepts (329)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Christopher Porter's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Christopher Porter has written about over time.
Hematopoietic Stem Cells, 6 publications between 2005 and 2021, average publication date September 2011. Cell Cycle Proteins, 4 publications between 2012 and 2017, average publication date January 2014. Nuclear Proteins, 3 publications between 2012 and 2017, average publication date July 2014. Protein-Tyrosine Kinases, 3 publications between 2012 and 2017, average publication date July 2014. Pyrimidines, 6 publications between 2009 and 2017, average publication date September 2014. Antineoplastic Combined Chemotherapy Protocols, 3 publications between 2014 and 2017, average publication date January 2016. Pyrazoles, 4 publications between 2013 and 2017, average publication date March 2016. Leukemia, 5 publications between 2005 and 2023, average publication date April 2017. Thrombocytopenia, 4 publications between 2015 and 2020, average publication date September 2017. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 8 publications between 2004 and 2023, average publication date January 2018. Neoplastic Syndromes, Hereditary, 2 publications between 2016 and 2019, average publication date April 2018. Proto-Oncogene Proteins c-ets, 5 publications between 2015 and 2022, average publication date September 2018. Repressor Proteins, 5 publications between 2015 and 2022, average publication date September 2018. Leukemia, Myeloid, Acute, 9 publications between 2012 and 2023, average publication date February 2019. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 3 publications between 2015 and 2023, average publication date February 2019. Germ-Line Mutation, 7 publications between 2015 and 2022, average publication date July 2019. Genetic Testing, 3 publications between 2019 and 2021, average publication date February 2020. Interleukin-12, 3 publications between 2019 and 2022, average publication date November 2020. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 2 publications between 2019 and 2023, average publication date June 2021. Burkitt Lymphoma, 2 publications between 2022 and 2023, average publication date November 2022.

To see the data from this visualization as text, click here.
Porter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)